Results 101 to 110 of about 100,739 (255)
What to Do with Epicardial Coronary Artery Abnormalities That do not Result in Myocardial Ischemia?
When epicardial arteries with minimal CAD do not limit flow are found at coronary angiography, all cardiologists agree that aggressive risk factor modification and use of appropriate drugs are warranted.
C. Richard Conti
doaj +1 more source
Drug-eluting balloon: is it useful?
Background Coronary artery disease is one of the major issues in the medical world around the globe. The prevalence tends to increase. The use of coronary intervention is one of the ways often used in the management of coronary artery disease due to its ...
Sidhi Laksono+2 more
doaj +1 more source
The LCX is the most prevalent culprit vessel with acute complete occlusion in NSTEMI patients, yet it has little effect on clinical outcomes. This subset of patients may be predicted by STV5 + STV6 ≥ 2.5 mm and T‐wave imbalance. ABSTRACT Background Complete blockage of the culprit coronary artery is associated with 30% of NSTEMI (non‐ST‐segment ...
Yongshi Wei+5 more
wiley +1 more source
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Thrombosis plays a major role in acute vessel closure both after coronary balloon angioplasty and after stenting. This review will address the role of antiplatelet and anticoagulant therapy in preventing early thrombotic complications after percutaneous ...
Verheugt Freek WA+2 more
doaj +1 more source
Coronary stenting versus balloon angioplasty in small vessels
We read with interest the study by Moreno et al. ([1][1]), which demonstrated, through ameta-analytic technique, the significant reduction of restenosis due to stent incomparison to percutaneous transluminal coronary angioplasty in small-vessel coronaryartery disease.
Agostoni, Pierfrancesco+2 more
openaire +3 more sources
POT-sideDCB-POT: A novel technique for treating coronary bifurcation lesions
The rePOT technique is a novel and easily applied approach for coronary bifurcations. Drug-Coated Balloon (DCB) angioplasty is increasingly being utilized in management of small vessels and coronary bifurcation lesions.
Georgios Tzanis+4 more
doaj
BackgroundPercutaneous coronary interventions (PCI) with drug-coated balloons (DCB) might be a promising trade-off between balloon angioplasty and drug-eluting stents, since DCB inhibit neointimal proliferation and limit duration of dual antiplatelet ...
T. Poerner+5 more
semanticscholar +1 more source
Coronary flow velocity reserve after percutaneous interventions is predictive of periprocedural outcome [PDF]
BACKGROUND: Because heterogeneous results have been reported, we assessed coronary flow velocity changes in individuals who underwent percutaneous transluminal coronary angioplasty (PTCA) and examined their impact on clinical outcome. METHODS AND RESULTS:
Albertal, M. (Mariano)+11 more
core
The strategy of surgical revascularization of coronary arteries in a multi-vessel lesion
This review presents the basic approaches for the surgical myocardial revascularization in patients with multivessel coronary lesions. The methods of coronary artery bypass grafting, balloon angioplasty, stenting using holometallic stents and drug-coated
Aleksandr V. Bocharov, Leonid V. Popov
doaj +1 more source
OBJECTIVES The percutaneous coronary artery angioplasty is routinely being used worldwide for the management of short and discrete coronary artery stenosis. The purpose of this report is to address the potentially lethal complication among the variety of
Jaswinder Singh+5 more
semanticscholar +1 more source